- Home
- ADSK vs BDX Comparison
ADSK vs BDX Comparison
Compare ADSK & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADSK
- BDX
- Stock Information
- Founded
- ADSK 1982
- BDX 1897
- Country
- ADSK United States
- BDX United States
- Employees
- ADSK N/A
- BDX N/A
- Industry
- ADSK Computer Software: Prepackaged Software
- BDX Medical/Dental Instruments
- Sector
- ADSK Technology
- BDX Health Care
- Exchange
- ADSK Nasdaq
- BDX Nasdaq
- Market Cap
- ADSK 62.7B
- BDX 64.5B
- IPO Year
- ADSK N/A
- BDX 1962
- Fundamental
- Price
- ADSK $284.61
- BDX $228.05
- Analyst Decision
- ADSK Buy
- BDX Strong Buy
- Analyst Count
- ADSK 23
- BDX 7
- Target Price
- ADSK $333.83
- BDX $278.29
- AVG Volume (30 Days)
- ADSK 1.4M
- BDX 2.1M
- Earning Date
- ADSK 02-27-2025
- BDX 02-05-2025
- Dividend Yield
- ADSK N/A
- BDX 1.81%
- EPS Growth
- ADSK 18.55
- BDX 41.25
- EPS
- ADSK 5.03
- BDX 5.94
- Revenue
- ADSK $5,961,000,000.00
- BDX $20,640,000,000.00
- Revenue This Year
- ADSK $13.63
- BDX $9.20
- Revenue Next Year
- ADSK $12.71
- BDX $4.99
- P/E Ratio
- ADSK $56.70
- BDX $38.72
- Revenue Growth
- ADSK 11.50
- BDX 5.89
- 52 Week Low
- ADSK $195.32
- BDX $218.75
- 52 Week High
- ADSK $326.62
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- ADSK 37.13
- BDX 43.00
- Support Level
- ADSK $280.51
- BDX $221.71
- Resistance Level
- ADSK $304.97
- BDX $231.87
- Average True Range (ATR)
- ADSK 6.65
- BDX 4.29
- MACD
- ADSK -2.45
- BDX -0.65
- Stochastic Oscillator
- ADSK 12.97
- BDX 26.96
About ADSK Autodesk Inc.
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction; product design and manufacturing; and media and entertainment. Autodesk software enables design, modeling, and rendering needs of these industries. The company has over 4 million paid subscribers across 180 countries.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.